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Twin studies have consistently found that genetic factors explain a substantial proportion of the variance
for insomnia. However, studies vary widely in their heritability estimates. Therefore, this meta-analysis
aimed to: 1) Estimate the mean heritability of insomnia; 2) Assess heterogeneity among twin studies of
insomnia; and 3) Search and analyse characteristics of the studies (moderator variables) that may explain
heterogeneity among estimates. For this purpose, separate meta-analyses were carried out for MZ and DZ
correlations and for heritability estimates by assuming random-effects models. Thirteen independent
samples were included in this meta-analysis. The heterogeneity index for heritability estimates was
significant in both best fitting models (I2 ¼ 98.77, P < .0001) and full models (I2 ¼ 97.80, P < .0001). MZ
correlations were higher (0.37; 95%CI: 0.31,.43) than DZ correlations (0.15; 95%CI: 0.12,.18). A mean
heritability of 0.39 (95%CI: 0.32,.44) was found for insomnia. These results highlight the role of genetic
factors in explaining differences among the population on insomnia and Emphasize heterogeneity
among studies. Further research is needed to identify variables that could explain this heterogeneity.
© 2021 Elsevier Ltd. All rights reserved.Introduction
Insomnia is characterised by a difficulty falling asleep or staying
asleep. As is the case for other sleep disorders, the aetiology of
insomnia is not fully understood [1], but both genetic and envi-
ronmental influences are assumed to play a role in its genesis and
development. Twin studies and, more recently, analyses using ge-
netic variants determination (e.g., polygenic risk scores) increase
our understanding of the interplay between genes and the envi-
ronment in insomnia, with the ultimate objective of offering clues
for improving our diagnostic and treatment capability.mon shared environmental
nia; D, non-additive genetic
opposite sex; E, non-shared
on studies; MZ, monozygotic
sychology, Faculty of Health
.
-Valero).Insomnia is highly prevalent and it is one of the most common
complaints in medical practice [1,2]. Prevalence estimates of
insomnia range from 6 to 33% depending on the definition used
[2e5]. Symptoms of insomnia occur despite adequate opportunities
for sleep and can impact daytime functioning [1,6]. Insomnia has
negative consequences for almost every single aspect of mental and
physical health, from chronic pain to psychosis [7e16]; and its
economic burden is high with an average annual per-person cost
(direct and indirect combined) of $5010 for individuals with an
insomnia disorder or $1431 for individuals presenting with symp-
toms, as compared to $421 for good sleepers. The largest proportion
of these expenses was attributable to work absences and reduced
productivity [17]. In another study, Medicare beneficiaries with
untreated insomnia had higher healthcare utilization and costs
across all points of service [18]. Helpful treatments for insomnia are
available. For instance, cognitive behavior therapy for insomnia
(CBT-I) has proven to be effective and cost-effective [19,20] and it is
often recommended as the treatment of choice [1], although it is
not always utilised the most [21].
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the precise nature of its aetiology remains elusive. Twin studies
have been one of themain sources of information about the relative
magnitude of genetic and environmental factors on the genesis and
development of insomnia. This method has proven to be a useful
tool for research [22] as twin studies allow the disentanglement of
genetic and environmental factors on a phenotype, trait or disorder
[23] and provide estimates of heritability, which can be defined as
the proportion of phenotypic variance explained by genetic factors.
Heritability can be estimated using a variety of genetically infor-
mative methods, but estimation from twin studies remain relevant
because of their ability to capture genetic effects as a whole,
including those of rare variants and the cumulated influence of
common genetic variants of tiny effect. In addition, twin studies
allow for the analysis of the relative impact of shared environ-
mental factors on a trait.
However, there is awide variety of results; heritability estimates
range from around 0.30 to 0.60 [24e27]. That is not surprising as
these studies have been performed in different populations, at
different times and in different locations; and heritability is a
population statistic which, therefore, may vary from one popula-
tion to another [28].
Heterogeneity in results can be explained in part by the
approach taken to assess heritability. GWAS studies have also been
used to estimate the variance of specific traits explained by genetic
factors. For example, a study with more than one million partici-
pants found that just 7% of the variance was attributable to the
genotyped variants [29]; a value which is notably lower than those
obtained from twin studies.
There is also heterogeneity between age groups. In adolescents,
heritability estimates range from14 to 41% [30e33]. In young adults
around 35% of the variance was explained by genetic factors [34]. In
adults, heritability estimates range from 0.28 to 0.43 [27,35e37].
Regarding sex, different heritability estimates were reported for
males and females in one study [24] but not in others [34,35,37].
The above cited literature consistently supports the substantial
role of genetics in explaining individual differences for insomnia,
although the magnitude of its impact varies between studies. There
is even greater uncertainty about the specific variables that could
potentially cause differences in the distribution of the genetic and
environmental influences for insomnia. Women usually have a
higher prevalence of insomnia than do men [38]. Gonadal steroid
effects have been proposed as a potential explanation for these
differences since sex differences in the prevalence of insomnia
begins at puberty and increases during and after the stage of life at
which females experience themenopause [39]. Nevertheless, mean
differences in terms of symptoms, do not necessarily imply genetic
and environment differences on the distribution of the variance. As
stated above, just one study found sex-differences for the herita-
bility estimates for insomnia [24]. This could be because many of
the studies were relatively small andmay have been underpowered
to detect sex differences. Age is another variable that could affect
the distribution of the variance on insomnia. Sleep changes
throughout the life-span and insomnia is associated with aging
[3,40,41]. Ethnicity is another variable that could potentially in-
fluence heritability estimates [42e44]. However, studies address-
ing these issues are not conclusive and most of them are limited to
US samples. Related to the previous point, latitude, which is asso-
ciated with hours of sun-light exposure, could also influence
insomnia; for example, a study that compared sleep in Norway
(69ºN) and Ghana (5ºN) found that lack of daylight was related to
increased problems falling asleep and daytime fatigue. Seasonal2
differences in insomnia were found in Norway but not in Ghana
[45].
Taking into account the wide variety of results across the studies
this meta-analysis aimed to: 1) Estimate the mean heritability of
insomnia; 2) Assess heterogeneity among twin studies on this
phenotype; and 3) Search and analyse characteristics of the studies
(moderator variables) that may explain the heterogeneity among
such studies.
Method
This meta-analysis was pre-registered on the Open Science
Framework (see for further information https://osf.io/5g839/).
Furthermore, this systematic review and meta-analysis was con-
ducted following the Preferred Reporting Items for Systematic Re-
views and Meta-analyses (PRISMA) guidelines [46]. Supplementary
Table 1 presents the PRISMA checklist for this systematic review.
Eligibility criteria
This meta-analysis focused on twin studies that provided an
estimation of the heritability of insomnia up until March 2020. All
studies that addressed insomnia or insomnia symptoms explicitly
were included. Studies that included indirect measures that were
not specifically referred to as insomnia symptoms (such as sleep
disturbances, awakenings, or sleep onset difficulties) were not
included. This was because they might have focused on variables
other than insomnia such as general sleep quality or sleep apnoea.
This approach also allowed consistency in the criterion for selec-
tion. Our search strategy included both objective and subjective
measures of insomnia. Nonetheless, there were no studies using
objective measures of insomnia that met the selection criteria.
As for the exclusion criteria, studies that did not use a twin
sample to estimate heritability (e.g., GWAS) were excluded. Studies
with a mean sample below 6 years old were also excluded since our
focus was not on insomnia in young children, which may differ
from that experienced at later stages of the life course as well as
sleep characteristics and patterns (e.g., school timetables or day-
time naps [47,48]). Only independent samples were included.
Hence, whenmore than one publication reported the heritability of
insomnia using the same sample (the same twin registry) we
selected the publication with: 1) greater detail (e.g., estimates for
men and women independently); 2) the larger sample; 3) esti-
mates from univariate models (rather than multivariate models) or
4) a more recent publication date.
Search strategy
The scientific search was conducted from the 1st to 30th of
March 2020 in PubMed (https://www.ncbi.nlm.nih.gov/pubmed/)
and Web of Science (https://apps.webofknowledge.com/). The
following keywords were used: insomnia AND monozygotic/dizy-
gotic/twin*/heritability. No filters for dates or language were
applied. However, conference papers were excluded since they
often do not report all the required information and are typically
published later as full research articles.
Applying these criteria, we found 82 and 144 results in PubMed
andWeb of Science respectively. Duplicates were removed yielding
a total of 153 that were screened. Of those, 31 results were assessed
and after applying the exclusion criteria, 10 articles were included
in the meta-analysis (Fig. 1). As some studies reported heritability
Fig. 1. Flow Chart of study selection process.
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13 units of analyses.
Data extraction
For all the studies the following characteristics of the studies
were extracted (as per a previous publication focusing on sleep
quality and duration [49]).
 Mean age of the study sample with standard deviation
 Proportion of males and females
 Proportion of monozygotic (MZ), dizygotic (DZ), dizygotic
opposite sex (DZOS) and non-twin siblings (if relevant)
 Country of origin of the study population
 Continent of origin of the study population
 Type of measure: single question or questions derived from a
validated questionnaire/validated instrument
 Best fitting model (ACE, ADE, AE, CE or E)
 Number of twin/siblings pairs in the study
 Number of participants in the study
 MZ and DZ correlations
 Components of the variance for the full model: we entered
the heritability (h2) and shared environmental component
(c2) under the ACE or ADE model. When the reported model
was an ACE model, the estimate for A was entered in h2_FULL
and C was entered in c2_FULL. When an ADE model was re-
ported, we summed A and D and entered the sum in h2_FULL
and zero for c2_FULL. If both univariate and multivariate an-
alyses were presented, estimates from univariate models were
included3
 Components of the variance for the BEST model: When the best
fitting model was an ACEmodel, we entered A for h2_BEST and C
was entered for c2_FULL. When the best fitting model was an
ADE, we entered the sum of A and D in h2_BEST and zero in
c2_BEST. If the best fitting model was an AE (or CE or E) we
entered zero for the component (or components) dropped and
the significant components were entered as previously
described
Data entry: All the studies were double coded by JJM-V and
MRA, disagreements were solved by consensus by third reviewer
(JRO or JSM). The results showed very satisfactory interrater reli-
ability, with kappa coefficients ranging from 0.95 to 1 (M¼ 0.97) for
the categorical variables and intraclass correlations between 0.97
and 1 (M¼ 0.98) for the continuous variables. Heath and colleagues
[36] provided heritability estimates from five different questions
(i.e., “initial insomnia; “disturbed sleep”; “anxious insomnia”;
“depressed insomnia” and “sleep delay”). For this unit of analysis,
the mean of the estimates for these five measures was calculated.
Statistical analyses
In this meta-analysis the outcome measures were monozygotic
and dizygotic twin correlations (rMZ and rDZ, respectively), and
estimates of heritability from the full and best fitting models
(h2_FULL and h2_BEST, respectively). These effect sizes were
transformed into the Fisher's Z metric in order to normalize dis-
tributions and stabilize variances.
Separate meta-analyses were carried out for rMZ, rDZ, h2_FULL
and h2_BEST by assuming random-effects models, as heterogeneity
Table 2
Mean effect sizes, 95% confidence intervals, and heterogeneity statistics of twin
correlations and variance components.
Statistic k ESþ 95% CI
LL UL
Q p I2
rMZ 13 0.37 0.31 0.43 90.18 <0.0001 89.23
rDZ 13 0.15 0.12 0.18 25.23 0.014 48.05
h2_FULL 7 0.41 0.32 0.49 181.78 <0.0001 97.80
h2_BEST 13 0.39 0.32 0.44 549.39 <0.0001 98.77
r ¼ correlation. MZ ¼ monozygotic twins. DZ ¼ dizygotic twins.
h2_FULL ¼ heritability estimates from the full model. h2_BEST ¼ heritability esti-
mates from the best fitting model. k ¼ number of studies. ESþ ¼ mean effect size
estimate. LL and UL: lower and upper limits of the 95% confidence interval for ESþ.
Q ¼ Cochran's heterogeneity Q statistic; Q statistic has k e 1 degrees of freedom.
p ¼ probability level for the Q statistic. I2 ¼ heterogeneity index.
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was used toweigh each effect size. The variancewas equal to the sum
of the sampling variance and the between-studies variance, as esti-
mated by restricted maximum likelihood [50]. For each meta-
analysis, a mean effect size was obtained and a 95%CI was con-
structedwiththe improvedmethoddevelopedbyHartungandKnapp
[51,52]. To facilitate the interpretation of the results, the mean effect
sizes and their confidence limits (calculated onFisher's Z transformed
effect sizes) were back transformed into a Pearson correlationmetric.
To check for variability among effect sizes, the Cochran's Q-statistic
and the I2 index (values of 0%, 25%, 50%, and 75% representing no, low,
moderate, and high heterogeneity, respectively) were used [53]. For
each meta-analysis, a forest plot was also constructed.
Publication bias was assessed by constructing funnel plots with
the trim-and-fill method which consists of imputing missing effect
sizes to achieve symmetry [54]. The Egger's regression test was also
applied [55]. A statistically significant result for the Egger test
(p < .10) was evidence of publication bias. Using p < .10 in place of
the usual p < .05 is due to the Egger test has low statistical power
with a small number of studies (k < 20), as it is the case [56].
Finally, in order to explain the heterogeneity among the effect
sizes, meta-regressions and weighted ANOVAs for continuous and
categorical moderators respectively, were applied by assuming a
mixed-effects model for each meta-analysis with at least 10 effect
sizes. An improved F statistic developed by Knapp and Hartung
[57,58] was applied for testing the statistical significance of each
moderator. QE and QW statistics were computed to test the model
misspecification for meta-regressions and weighted ANOVAs,
respectively, and an estimate of the proportion of variance
explained by each moderator, R2, was also calculated [59]. All sta-
tistical analyses were conducted with metafor program in R [60].
Results
Characteristics of the included studies
All the studies used the classical twin design, which make use of
the difference between MZ and DZ twins within-pair correlations,
to estimate the genetic and environmental influences on insomnia.
One study reported data from women only [27] and another only
men [26]. Studies were carried out using samples from: North
America (5), Europe (4) and Oceania (1). Actually, just four coun-
tries provided data: USA (5), UK (3), Finland (1) and Australia (1).
Three studies had data available for males and females separately
and therefore, they provided two units of analyses (i.e., one for
males and one for females) [24,35,37]. Gregory et al. [34], Lind et al.Table 1
Main characteristics of the studies included in the meta-analysis.
Study N Validated questi
1 Heath et al., 1990 [36] 3810 pairs NO
2 McCarren et al., 1994 [26] 2825 pairs YES
3 Watson et al., 2006 [25] 1870 pairs NO
4 Hublin et al., 2011 [35] 4545 pairs NO
5 Drake et al., 2011 [37] 1782 participants NO
6 Hur et al., 2012 [27] 3758 participants NO
7 Barclay et al., 2015 [30] 2822 participants NO
8 Lind et al., 2015 [24] 7500 participants NO
9 Gregory et al., 2016 [34] 1556 participants YES
10 Madrid-Valero et al., 2020 [33] 10,222 participants YES
A: males; B: females.
Note: Questionnaires used to measure insomnia were: brief self-reported scale by Jenking
severity index for McCarren et al., 1994, Gregory et al., 2016 and Madrid-Valero et al., 2
4
[24], and Barclay et al. [30], reported heritability estimates from
different waves of data collection. The wave with larger number of
participants was selected (Table 1).
Mean effect size and heterogeneity
Table 2 presents the results of the meta-analyses carried out for
twin correlations (rMZ and rDZ) and variance components
(h2_FULL and h2_BEST). Fig. 2 displays the forest plots for rMZ, rDZ,
h2_FULL and h2_BEST.
Thirteen studies reported the MZ and DZ correlations and the
heritability estimates from the best fitting model. There were seven
heritability estimates from full models. Themean effect size for rMZ
was ESþ ¼ 0.37 (95% CI ¼ 0.31, 0.43), and for rDZ was ESþ ¼ 0.15
(95% CI ¼ 0.12, 0.18). Similar mean effect sizes were found for
heritability estimates, being ESþ ¼ 0.41 (95% CI ¼ 0.32, 0.49) for
h2_FULL and ESþ ¼ 0.39 (95%CI ¼ 0.32, 0.44) for h2_BEST.
Great heterogeneity among the effect sizes for rMZ, rDZ,
h2_FULL and h2_BEST was found (I2 > 75% and p < .0001, except for
rDZ where I2 ¼ 48%) (see Table 2). This considerable heterogeneity
is also reflected in the forest plots (see Fig. 2).
Analysis of publication bias
Publication bias was analysed by constructing a funnel plot and
assessing its asymmetry with the trim-and-fill method and the
Egger test.
Fig. 3 presents the funnel plots for rMZ, rDZ, h2_FULL and
h2_BEST. Applying the trim-and-fill method, no effect sizes had to
be imputed for MZ and DZ twin correlations and h2_BEST (see
Fig. 3A, B and 3D). For the h2_FULL, an additional effect sizeonnaire Continent (Country) Age %Males H2 Insomnia
Oceania (Australia) / 36 0.34
America (USA) / 100 0.28
America (USA) x ¼ 32 39 0.57












Europe (UK) x ¼ 50 0 0.28
America (USA) x ¼ 12 46 0.33






Europe (UK) x ¼ 20.3 38 0.35
Europe (UK) x ¼ 16.3 44.8 0.41
s and colleagues, 6 items from the insomnia symptoms questionnaire and insomnia
020 respectively.
Fig. 2. Forest plots displaying MZ (A) and DZ (B) twin correlations, and heritability estimates from the full (C) and best-fitting (D) models, with 95% confidence intervals. RE
(Random-Effects) Model refers to the statistical model assumed in the calculations.
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mates to achieve symmetry in the funnel plot (see Fig. 3C). The
adjusted mean effect size, once corrected by publication bias, was
ESadj ¼ 0.40 (95%CI ¼ 0.31, 0.49). Compared with the original mean
effect size obtained with the seven studies (ESþ ¼ 0.41), the
adjusted mean effect size barely changed, with a negligible
decrease of 2.40%.
Non-significant results for the interception were obtained from
the Egger test for MZ twin correlations (t(11) ¼ 1.00; p ¼ .338), DZ
twin correlations (t(11) ¼ 0.13; p ¼ .898), heritability estimates
from the full model (t(5)¼ 1.05; p¼ .343) and heritability estimates
from the best fitting model (t(11) ¼ 1.30; p ¼ .219).Analyses of moderator variables
The large variability found among the effect sizes led to the
analysis of potential moderator variables. These analyses were
applied to those meta-analyses with at least 10 effects sizes, i.e.,
rMZ, rDZ, and h2_BEST.
Table 3 presents the results of the simple meta-regressions
performed on several continuous moderators. We were not able
to analyse quantitative moderators for rMZ and rDZ due to the lack
of available information. None of the analysed moderators reached
a statistically significant association with the h2_BEST.5
Continent where the study took place and the use of a validated
questionnaire were also analysed, as categorical moderators, by
means of the weighted ANOVAs models. Table 4 presents those
results. None of them reached a statistically significant association
with MZ and DZ twin correlations or heritability estimates from the
best fitting model.Discussion
This study meta-analysed twin studies that estimated the
magnitude of genetic and environmental influences on insomnia.
As expected, we found that genetic factors play a substantial role in
explaining variability for insomnia. The mean effect size for genetic
influences on insomnia was 0.39 (95%CI: 0.32,.44) from the best
fitting models. This result is similar to the heritability estimates for
sleep quality and sleep duration reported in another recent meta-
analysis by our group [49]. Furthermore, our results also reveal
high heterogeneity among studies.
Regarding the distribution of the variance, non-shared envi-
ronmental influences were the main source of variation with
values ranging from 0.43 to 0.72. Genetic influences were also
substantial with values ranging from 0.28 to 0.57. In contrast,
shared-environmental influences had a negligible impact in all
the studies. This is in line with the wider behavior genetic
Fig. 3. Funnel plots of MZ (A) and DZ (B) twin correlations, and heritability estimates from the full (C) and best-fitting (D) models. The white circle is the imputed heritability
estimate by means of the Duval and Tweedie's trim and-fill method.
Table 3
Results of the simple meta-regressions applied on heritability estimates from the
best fitting model, taking continuous moderator variables as predictors.
Predictor variable k bj F p QE R2
h2_BEST
Mean age (years) 11 0.001 0.07 0.805 460.29*** 0
Gender (% male) 13 0.001 0.35 0.568 528.69*** 0
% of MZ 13 0.004 1.04 0.329 541.03*** 0
% of DZ 13 0.004 1.09 0.320 539.84*** 0
% of DOS 9 0.004 0.95 0.363 345.57*** 0
MZ¼monozygotic twins. DZ¼ dizygotic twins. DOS¼ dizygotic twins, opposite sex.
k ¼ number of studies. bj ¼ regression coefficient of each predictor. F ¼ Knapp-
Hartung's statistic for testing the significance of the predictor (the degrees of
freedom for this statistic are one for the numerator and k e 2 for the denominator).
p ¼ probability level for the F statistic. QE ¼ statistic for testing the model mis-
specification. R2 ¼ proportion of variance accounted for by the predictor.
***p < .0001. *p < .01.
Table 4
Results of the weighted ANOVAs applied on monozygotic twin correlations, dizy-
gotic twin correlations and heritability estimates from the best fitting model, taking
qualitative moderator variables as independent variables.
Predictor variable k ESþ 95% CI ANOVA results
LL LU
rMZ
Continent: F2,10 ¼ 0.03, p ¼ .972
N. America 7 0.38 0.29 0.46 R2 ¼ 0
Europe 5 0.37 0.27 0.47 QW(10) ¼ 86.11, p < .001
Oceania 1 0.35 0.11 0.55
Validated questionnaire: F1,11 ¼ 0.15, p ¼ .702
No 10 0.38 0.31 0.44 R2 ¼ 0
Yes 3 0.35 0.22 0.47 QW(11) ¼ 89.99, p < .001
rDZ
Continent: F2,10 ¼ 0.45, p ¼ .651
N. America 7 0.14 0.09 0.19 R2 ¼ 0
Europe 5 0.17 0.12 0.22 QW(10) ¼ 22.12, p ¼ .015
Oceania 1 0.15 0.05 0.25
Validated questionnaire: F1,11 ¼ 0.61, p ¼ .452
No 10 0.15 0.11 0.19 R2 ¼ 0
Yes 3 0.17 0.11 0.23 QW(11) ¼ 23.87, p ¼ .013
h2_BEST
Continent: F2,10 ¼ 0.14, p ¼ .873
N. America 7 0.39 0.30 0.49 R2 ¼ 0
Europe 5 0.38 0.26 0.48 QW(10) ¼ 523.28, p < .001
Oceania 1 0.34 0.07 0.56
Validated questionnaire: F1,11 ¼ 0.49, p ¼ .497
No 10 0.39 0.32 0.47 R2 ¼ 0
Yes 3 0.35 0.21 0.48 QW(11) ¼ 547.30, p < .001
k ¼ number of studies. ESþ ¼ average effect size estimate. LL and LU ¼ lower and
upper 95% confidence limits for ESþ. F ¼ Knapp-Hartung's statistic for testing the
significance of the moderator variable. QW ¼ statistic for testing the model mis-
specification. R2 ¼ proportion of variance accounted for by the moderator.
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detectable [61] for many traits. This is also consistent with the
aforementioned meta-analysis on sleep quality and sleep dura-
tion, where just two studies on sleep duration reported common-
shared environmental influences and both influences were of
small magnitude [49].
GWAS have also confirmed the role of genes in explaining inter-
individual differences on this trait. For example, Jansen et al. [29],
in a study using more than one million participants, estimated
SNP-based heritability for insomnia at 7%. This value is notably
lower than those obtained from twin studies reported here. Such a
divergence in estimates between twin and SNP-based studies is
found frequently in different traits and represents the issue of so-6
Practice points
1 This review confirms that insomnia is moderately influ-
enced by genetic factors
2 Results from this study highlight that non-shared envi-
ronmental influences are the main source of variance for
insomnia
3 Common shared environmental factors have a negligible
impact on insomnia in participants who are older than six
years of age
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ference in heritability estimated from twin studies and those
assessing genetic variants (i.e., SNPs) include that SNP methods
fail to capture the influence of many common variants of very
small effect and also of rare variants with large effects. Further-
more, twin studies may involve specific effects such as
geneeenvironment correlation that are not captured by SNP-
based methods [62e64]. In the aforementioned study more than
200 loci implicating 956 genes were identified. This study also
supported the link between sleep disorders and psychiatric dis-
orders, findings that have extensively reported using twin samples
[33,65e67]. Other GWAS studies have also found significant ge-
netic correlations between insomnia and alcohol use, nicotine use
and opioid use [68]. A Recent GWAS also demonstrated that ge-
netic variation associated with brain structure also affects
insomnia [69]. Research about the aetiology of insomnia is
essential for many reasons. The more we know the more we
advance in our endeavor of developing preventing strategies as
well as more accurate and effective treatments, such as tailored
interventions. It has been proposed that there might be two types
of insomnia, onewith a more biological origin [70]. If this theory is
supported it could suggest that different treatments should be
used for each type of insomnia and genetic research will be
essential in clarifying this. Finally, these findings are also relevant
from a clinical perspective. It has been demonstrated that per-
ceptions about the aetiology of a disorder could influence per-
ceptions and attitudes regarding different treatments and
clinicians' empathy [71,72].
As stated above, there was significant heterogeneity among
studies. Nevertheless, none of the moderators considered (e.g.,
age, sex, continent, or type of measure) could explain the vari-
ability among the studies. Age and sex are two of the most
studied variables associated with insomnia. Female sex is a risk
factor for insomnia and poor sleep quality, which also appears to
worsen with increasing age [38,40]. Despite the scientific litera-
ture consistently supporting these findings, our results did not
provide any evidence for a significant effect of age or sex. This
failure to detect the effect of these moderators could be due to
the limited number of studies included in the meta-analysis or
because most of the studies did not specifically assess age and
sex in their analyses. Results from the studies which reported
heritability estimates for males and females separately revealed
that estimates are quite similar. These results are consistent with
other sleep phenotypes, specifically sleep duration and sleep
quality where no moderators were found in a previous meta-
analysis [49].
There was no evidence of publication bias. Publication bias is
unlikely for twin studies since they possess characteristics such as
large samples and relevant effect sizes (typically heritability esti-
mates are around 30e50%). Moreover, low heritability estimates
are as interesting as high heritability values [61].
Strengths and limitations
This study has several strengths such as the use of a meta-
analytic approach to estimate the mean effect size of heritabili-
ty estimates. Furthermore, as previously mentioned, twin studies
typically use large twin samples, and high and low heritability
estimates are equally interesting. All the studies included here
flagged significant heritability estimates for insomnia. In addition
to this, both best fitting and full models were meta-analysed,
since estimates from best fitting models could be affected by7
the sample size. We found very similar results using both ap-
proaches. Despite these strengths this study also has some lim-
itations. First, the number of studies was limited: only 10
independent samples (13 units of analyses) were included. These
studies came from just four different countries which means that
their representativeness could be limited. Furthermore, some
studies did not report all of the statistics. For example, while all
units of analyses were available for the best fitting model, just 7
units of analyses reported data for the full model which
hampered the comparison between full and best fitting models.
Additionally, most of the studies did not provide data for males
and females separately and the same applies for different age
ranges, which hampered the search for moderators. In light of
these factors, we encourage behavior genetic researchers to
report data from all models and, if relevant, sex comparisons and
sex-limitation models. Regarding the measurement of insomnia,
it is important to highlight that no studies estimated the heri-
tability of insomnia using objective methods (this is noteworthy,
although unsurprising given that insomnia is largely considered a
subjective complaint e best assessed using subjective measures).
Finally, despite the large heterogeneity demonstrated by the ef-
fect sizes, we have not been able to identify moderators of such
variability. This could be due to the limited number of studies
included in our meta-analysis. Other hidden moderators not re-
ported in the studies could also affect heritability estimates of
insomnia. Therefore, the small number of studies invites a
cautious interpretation of the results of moderator analyses.
Conclusions
There is significant heterogeneity in genetic and environmental
influences on insomnia from twin samples. Around 40% of the
variance in insomnia is explained by genetic factors. Further
research using different samples is needed (especially in those
populations with unique characteristics for sleep such as a specific
geography or climate) to identify possible moderators.
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